Terms: = Liver cancer AND CDKN2A, CDK4I, 1029, ENSG00000147889, P42771, p14, CMM2, ARF, TP16, p16, MTS1, p19, p16INK4a, INK4a, CDKN2, p16INK4, p14ARF, MLM, INK4 AND Diagnosis
87 results:
1. NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study.
Boyd S; Mustamäki T; Sjöblom N; Nordin A; Tenca A; Jokelainen K; Rantapero T; Liuksiala T; Lahtinen L; Kuopio T; Kytölä S; Mäkisalo H; Färkkilä M; Arola J
Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38551383
[TBL] [Abstract] [Full Text] [Related]
2. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
3. First-in-human study of PSMA-targeting agent, [
Zhao R; Ke M; Lv J; Liu S; Liu Y; Zhang J; Xu L; Gu D; Li M; Cai C; Liu Y; Zeng G; Alexoff D; Ploessl K; Zhu L; Kung HF; Wang X
Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1753-1762. PubMed ID: 38212531
[TBL] [Abstract] [Full Text] [Related]
4. Precision medicine for KRAS wild-type pancreatic adenocarcinomas.
Ben-Ammar I; Rousseau A; Nicolle R; Tarabay A; Boige V; Valery M; Pudlarz T; Malka D; Gelli M; Fernandez-De-Sevilla E; Fuerea A; Tanguy ML; Rouleau E; Barbe R; Mathieu JRR; Jaulin F; Smolenschi C; Hollebecque A; Ducreux M; Boileve A
Eur J Cancer; 2024 Jan; 197():113497. PubMed ID: 38134480
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive analysis of cancer of unknown primary and recommendation of a histological and immunohistochemical diagnostic strategy from China.
Ren M; Cai X; Jia L; Bai Q; Zhu X; Hu X; Wang Q; Luo Z; Zhou X
BMC Cancer; 2023 Dec; 23(1):1175. PubMed ID: 38041048
[TBL] [Abstract] [Full Text] [Related]
6. Cuproptosis-related prognostic signatures predict the prognosis and immunotherapy in HCC patients.
Peng H; Zou Z; Xiang Z; Lu X; Zhang Y; Peng X
Medicine (Baltimore); 2023 Aug; 102(34):e34741. PubMed ID: 37653738
[TBL] [Abstract] [Full Text] [Related]
7. Bile duct adenoma and small-sized small duct type intrahepatic cholangiocarcinoma show distinct differences in genetic alterations, expression of IMP3 and EZH2 and stromal and inflammatory components.
Sasaki M; Sato Y; Nakanuma Y
Histopathology; 2023 Aug; 83(2):298-309. PubMed ID: 37140546
[TBL] [Abstract] [Full Text] [Related]
8. Combined Hepatocellular-Cholangiocarcinoma With Ductal Plate Malformation Pattern: A Case Report With Molecular Analysis.
Moon WS; Song JS; Yu HC; Kim KM; Ahn AR
Int J Surg Pathol; 2024 Feb; 32(1):160-164. PubMed ID: 37128663
[TBL] [Abstract] [Full Text] [Related]
9. Primary and secondary angiosarcomas of the liver: a multi-institutional study of 32 cases.
Liao X; Lai J; Lin J; Zhang D
Hum Pathol; 2023 Jul; 137():10-17. PubMed ID: 37054784
[TBL] [Abstract] [Full Text] [Related]
10. Radiomics based on preoperative rectal cancer MRI to predict the metachronous liver metastasis.
Li ZF; Kang LQ; Liu FH; Zhao M; Guo SY; Lu S; Quan S
Abdom Radiol (NY); 2023 Mar; 48(3):833-843. PubMed ID: 36529807
[TBL] [Abstract] [Full Text] [Related]
11. Pancreatoblastoma in Elderly Adults: Report of Two Patients.
Kulak O; Osipov A; Hendifar AE; Nissen NN; Cox BK; Hruban RH; Hutchings DA
Int J Surg Pathol; 2023 Aug; 31(5):772-777. PubMed ID: 36314453
[No Abstract] [Full Text] [Related]
12. Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma.
Ma Y; Qiu C; Wang B; Zhang X; Wang X; Aguilera RJ; Zhang JY
Cells; 2022 Oct; 11(20):. PubMed ID: 36291095
[TBL] [Abstract] [Full Text] [Related]
13. ink4 cyclin-dependent kinase inhibitors as potential prognostic biomarkers and therapeutic targets in hepatocellular carcinoma.
Liu H; Jia S; Guo K; Li R
Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35771229
[TBL] [Abstract] [Full Text] [Related]
14. Preoperative serum ctDNA predicts early hepatocellular carcinoma recurrence and response to systemic therapies.
Fu Y; Yang Z; Hu Z; Yang Z; Pan Y; Chen J; Wang J; Hu D; Zhou Z; Xu L; Chen M; Zhang Y
Hepatol Int; 2022 Aug; 16(4):868-878. PubMed ID: 35674872
[TBL] [Abstract] [Full Text] [Related]
15. Genetic, Clinicopathological, and Radiological Features of Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation Pattern.
Chung T; Rhee H; Shim HS; Yoo JE; Choi GH; Kim H; Park YN
Gut Liver; 2022 Jul; 16(4):613-624. PubMed ID: 34810298
[TBL] [Abstract] [Full Text] [Related]
16. Aberrant STAT1 methylation as a non-invasive biomarker in blood of HCV induced hepatocellular carcinoma.
Zakir U; Siddiqui NN; Naqvi FU; Khan R
Cancer Biomark; 2022; 34(1):95-103. PubMed ID: 34657877
[TBL] [Abstract] [Full Text] [Related]
17. Distant metastases in squamous cell carcinoma of the pharynx and larynx: a population-based DAHANCA study.
Kjems J; Zukauskaite R; Johansen J; Eriksen JG; Lassen P; Andersen E; Andersen M; Farhadi M; Overgaard J; Vogelius IR; Friborg J
Acta Oncol; 2021 Nov; 60(11):1472-1480. PubMed ID: 34369265
[TBL] [Abstract] [Full Text] [Related]
18. Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis.
Itakura J; Kurosaki M; Setoyama H; Simakami T; Oza N; Korenaga M; Tanaka M; Torimura T; Sakamoto N; Enomoto N; Ueno Y; Kawada N; Kaneko S; Nishiguchi S; Chayama K; Tanaka J; Izumi N; Kanto T
J Gastroenterol; 2021 May; 56(5):470-478. PubMed ID: 33791882
[TBL] [Abstract] [Full Text] [Related]
19. ACOX2 is a prognostic marker and impedes the progression of hepatocellular carcinoma via PPARα pathway.
Zhang Q; Zhang Y; Sun S; Wang K; Qian J; Cui Z; Tao T; Zhou J
Cell Death Dis; 2021 Jan; 12(1):15. PubMed ID: 33414412
[TBL] [Abstract] [Full Text] [Related]
20. Identifying an oligometastatic phenotype in HPV-associated oropharyngeal squamous cell cancer: Implications for clinical trial design.
Fleming CW; Ward MC; Woody NM; Joshi NP; Greskovich JF; Rybicki L; Xiong D; Contrera K; Chute DJ; Milas ZL; Frenkel CH; Brickman DS; Carrizosa DR; Ku J; Prendes B; Lamarre E; Lorenz RR; Scharpf J; Burkey BB; Schwartzman L; Geiger JL; Adelstein DJ; Koyfman SA
Oral Oncol; 2021 Jan; 112():105046. PubMed ID: 33129058
[TBL] [Abstract] [Full Text] [Related]
[Next]
